490 related articles for article (PubMed ID: 25940580)
1. Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.
van der Linden M; Perniciaro S; Imöhl M
BMC Infect Dis; 2015 May; 15():207. PubMed ID: 25940580
[TBL] [Abstract][Full Text] [Related]
2. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
[TBL] [Abstract][Full Text] [Related]
3. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M
PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078
[TBL] [Abstract][Full Text] [Related]
4. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children.
van der Linden M; Reinert RR; Kern WV; Imöhl M
BMC Infect Dis; 2013 Feb; 13():70. PubMed ID: 23384407
[TBL] [Abstract][Full Text] [Related]
6. Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.
Kaur R; Casey JR; Pichichero ME
Pediatr Infect Dis J; 2016 Aug; 35(8):901-6. PubMed ID: 27420806
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016.
Siira L; Vestrheim DF; Winje BA; Caugant DA; Steens A
Vaccine; 2020 Jul; 38(34):5454-5463. PubMed ID: 32616324
[TBL] [Abstract][Full Text] [Related]
8. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13.
Redin A; Ciruela P; de Sevilla MF; Gomez-Bertomeu F; Gonzalez-Peris S; Benitez MA; Trujillo G; Diaz A; Jou E; Izquierdo C; Perez-Moreno MO; Moraga-Llop F; Olsina M; Vinado B; Sanfeliu E; Garcia A; Gonzalez-di Lauro S; Garcia-Garcia JJ; Dominguez A; Sa-Leao R; Muñoz-Almagro C;
Microbiol Spectr; 2021 Dec; 9(3):e0115021. PubMed ID: 34878302
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany.
van der Linden M; Winkel N; Küntzel S; Farkas A; Perniciaro SR; Reinert RR; Imöhl M
PLoS One; 2013; 8(4):e60848. PubMed ID: 23593324
[TBL] [Abstract][Full Text] [Related]
10. Nationwide surveillance of paediatric invasive and non-invasive pneumococcal disease in Japan after the introduction of the 13-valent conjugated vaccine, 2015-2017.
Nakano S; Fujisawa T; Ito Y; Chang B; Matsumura Y; Yamamoto M; Suga S; Ohnishi M; Nagao M
Vaccine; 2020 Feb; 38(7):1818-1824. PubMed ID: 31882246
[TBL] [Abstract][Full Text] [Related]
11. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
12. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.
Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L;
J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725
[TBL] [Abstract][Full Text] [Related]
13. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A;
Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556
[TBL] [Abstract][Full Text] [Related]
14. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
[TBL] [Abstract][Full Text] [Related]
15. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
16. Serotype distribution and penicillin-non-susceptibility of Streptococcus pneumoniae causing invasive diseases in Kuwait: A 10-year study of impact of pneumococcal conjugate vaccines.
Mokaddas E; Albert MJ
Expert Rev Vaccines; 2016 Oct; 15(10):1337-45. PubMed ID: 27267070
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal serotype evolution in Western Europe.
Tin Tin Htar M; Christopoulou D; Schmitt HJ
BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
[TBL] [Abstract][Full Text] [Related]
18. Regional variations in serotype distribution and vaccination status in children under six years of age with invasive pneumococcal disease in Germany.
Perniciaro S; Imöhl M; Fitzner C; van der Linden M
PLoS One; 2019; 14(1):e0210278. PubMed ID: 30625215
[TBL] [Abstract][Full Text] [Related]
19. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
De Wals P; Lefebvre B; Deceuninck G; Longtin J
Vaccine; 2018 Jan; 36(3):421-426. PubMed ID: 29224962
[TBL] [Abstract][Full Text] [Related]
20. The changing epidemiology of invasive pneumococcal disease after PCV13 vaccination in a country with intermediate vaccination coverage.
Ciruela P; Izquierdo C; Broner S; Muñoz-Almagro C; Hernández S; Ardanuy C; Pallarés R; Domínguez A; Jané M;
Vaccine; 2018 Nov; 36(50):7744-7752. PubMed ID: 30473132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
